1. Home
  2. CPIX vs SYTA Comparison

CPIX vs SYTA Comparison

Compare CPIX & SYTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • SYTA
  • Stock Information
  • Founded
  • CPIX 1999
  • SYTA N/A
  • Country
  • CPIX United States
  • SYTA Canada
  • Employees
  • CPIX N/A
  • SYTA N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • SYTA Telecommunications Equipment
  • Sector
  • CPIX Health Care
  • SYTA Telecommunications
  • Exchange
  • CPIX Nasdaq
  • SYTA Nasdaq
  • Market Cap
  • CPIX 40.1M
  • SYTA 38.2M
  • IPO Year
  • CPIX 2009
  • SYTA 2020
  • Fundamental
  • Price
  • CPIX $3.52
  • SYTA $3.75
  • Analyst Decision
  • CPIX
  • SYTA
  • Analyst Count
  • CPIX 0
  • SYTA 0
  • Target Price
  • CPIX N/A
  • SYTA N/A
  • AVG Volume (30 Days)
  • CPIX 102.7K
  • SYTA 3.6M
  • Earning Date
  • CPIX 08-05-2025
  • SYTA 08-15-2025
  • Dividend Yield
  • CPIX N/A
  • SYTA N/A
  • EPS Growth
  • CPIX N/A
  • SYTA N/A
  • EPS
  • CPIX N/A
  • SYTA N/A
  • Revenue
  • CPIX $41,083,299.00
  • SYTA $11,740,024.00
  • Revenue This Year
  • CPIX N/A
  • SYTA $18.41
  • Revenue Next Year
  • CPIX N/A
  • SYTA N/A
  • P/E Ratio
  • CPIX N/A
  • SYTA N/A
  • Revenue Growth
  • CPIX 5.82
  • SYTA 33.58
  • 52 Week Low
  • CPIX $1.04
  • SYTA $0.93
  • 52 Week High
  • CPIX $7.25
  • SYTA $93.60
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 47.41
  • SYTA 50.96
  • Support Level
  • CPIX $3.26
  • SYTA $3.72
  • Resistance Level
  • CPIX $3.97
  • SYTA $4.56
  • Average True Range (ATR)
  • CPIX 0.35
  • SYTA 0.58
  • MACD
  • CPIX 0.09
  • SYTA -0.06
  • Stochastic Oscillator
  • CPIX 53.09
  • SYTA 21.86

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About SYTA Siyata Mobile Inc.

Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.

Share on Social Networks: